Analyst Activity – Aegis Reiterates Buy on Inovio Pharmaceuticals (NASDAQ:INO)

ME Staff
-
0

Analyst Ratings For Inovio Pharmaceuticals (NASDAQ:INO)

Today, Aegis reiterated its Buy rating on Inovio Pharmaceuticals (NASDAQ:INO) with a price target of $14.00.

There are 2 hold ratings, 7 buy ratings on the stock.

The current consensus rating on Inovio Pharmaceuticals (NASDAQ:INO) is Buy (Score: 2.78) with a consensus target price of $22.11 per share, a potential 184.57% upside.

Some recent analyst ratings include

  • 7/18/2017-Aegis Reiterated Rating of Buy.
  • 6/8/2017-Piper Jaffray Companies Upgrade from a “Neutral ” rating to a ” Overweight” rating.
  • 5/25/2017-Stifel Nicolaus Reiterated Rating of Buy.
  • 5/1/2017-Nomura Reiterated Rating of Buy.
  • 5/1/2017-Jefferies Group LLC Reiterated Rating of Neutral.

Recent Insider Trading Activity For Inovio Pharmaceuticals (NASDAQ:INO)
Inovio Pharmaceuticals (NASDAQ:INO) has insider ownership of 10.60% and institutional ownership of 27.74%.

  • On 5/25/2017 David B Weiner, Director, sold 8,000 with an average share price of $8.00 per share and the total transaction amounting to $64,000.00. View SEC Filing
  • On 3/31/2017 Jong Joseph Kim, CEO, sold 147,180 with an average share price of $6.54 per share and the total transaction amounting to $962,557.20. View SEC Filing
  • On 3/27/2017 Morton Collins, Director, bought 21,300 with an average share price of $6.25 per share and the total transaction amounting to $133,125.00. View SEC Filing
  • On 8/29/2016 Niranjan Sardesai, COO, sold 21,800 with an average share price of $9.30 per share and the total transaction amounting to $202,740.00. View SEC Filing
  • On 6/28/2016 Morton Collins, Director, bought 10,000 with an average share price of $9.13 per share and the total transaction amounting to $91,300.00. View SEC Filing
  • On 5/18/2016 Simon X Benito, Director, sold 6,250 with an average share price of $10.37 per share and the total transaction amounting to $64,812.50. View SEC Filing
  • On 4/15/2016 Morton Collins, Director, bought 68,400 with an average share price of $9.52 per share and the total transaction amounting to $651,168.00. View SEC Filing

Recent Trading Activity for Inovio Pharmaceuticals (NASDAQ:INO)
Shares of Inovio Pharmaceuticals closed the previous trading session at 7.84 up +0.07 0.95% with 593,640 shares trading hands.